Status:
COMPLETED
A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief
Lead Sponsor:
Alcon Research
Collaborating Sponsors:
Matthew Caldwell
Conditions:
Photorefractive Keratectomy
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery.
Eligibility Criteria
Inclusion
- 19 years or older with healthy ocular status and pre-operative refractive anisometropia of less than 2.000 diopters between eyes undergoing bilateral PRK surgery.
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Those desiring PRK in only one eye, those in need of additional topical eye medications, those with history of drug/alcohol abuse, women breastfeeding or pregnant.
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00330798
Start Date
February 1 2006
End Date
June 1 2006
Last Update
November 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lackland Air Force Base
San Antonio, Texas, United States, 78236